ArticleBreast cancer research and treatment2025

Clinicopathologic features and contralateral breast cancer risk in BRCA1/2 pathogenic variant carriers: a multicenter registry study of Japanese women.

Kanae Taruno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.